Clofibrate Reversal of Platelet Hypersensitivity in Hyperbetalipoproteinemia

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Circulation

• Publication date

  1974-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.50.3.570PMID 4369866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet function in hyperlipoproteinemia.

  1974cited by this paper
• Critical role of the carbohydrate side chains of collagen in platelet aggregation.

  1972cited by this paper
• Clofibrate in coronary heart disease. Effect on morbidity and mortality.

  1972cited by this paper
• Preparation of Suspensions of Washed Platelets from Humans

  1972cited by this paper
• Gel Filtration

  1971cited by this paper
• Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate

  1971cited by this paper
• Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGION*

  1971cited by this paper
• Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP.

  1970cited by this paper
• Effect of clofibrate on platelet economy in man.

  1967cited by this paper
• Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.

  1966cited by this paper
• Some Effects of Fibrinogen Degradation Products (FDP) on Blood Platelets

  1966cited by this paper
• A Comparison of Platelet Stickiness Tests during an Atromid-S Trial

  1966cited by this paper
• A CONTROLLED TRIAL OF ATROMID IN CEREBRAL VASCULAR DISEASE. A PRELIMINARY REPORT.

  1963cited by this paper
• Preparation and properties of soluble collagens

  1963cited by this paper
• EFFECT OF ATROMID ON PLATELET STICKINESS.

  1963cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Clopidogrel or Prasugrel reduces mortality and lessens cardiovascular damage from acute myocardial infarction in Hypercholesterolemic male rats.

  2020cites this paper
• Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product.

  2014cites this paper
• Drugs that Affect Platelet Function

  2012cites this paper
• The role of membrane lipid microdomains (Rafts) in FcγRIIA effector functions.

  2010cites this paper
• Prickly pear changes 111 indium-LDL and 111 indium-HDL platelet binding Correlating to improvement of platelet function in hypercholesterolemia

  2010cites this paper
• The r ole of membrane lipid microdomains (raft s) in FcRIIA effec tor functions

  2010cites this paper
• Haemostatic and lipid abnormalities in hypothyroidism.

  2009cites this paper
• Platelets intravascular coagulation and fibrinolysis in hyperlipidaemias: relationship to thrombo-embolic complications.

  2009cites this paper
• Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.

  2009cites this paper
• [Antiplatelet effects of micronized fenofibrate in subjects with dyslipidemia].

  2007cites this paper
• Blood Tests for the Diagnosis of Venous and Arterial Thrombosis

  2005cites this paper
• CLOFIBRATE THERAPY IN HYPERLIPOPROTEINEMIA / Harker and Hazzard bound 125 I . Fibrinogen survival ( the average time in

  2005cites this paper
• Binding of m In-Labeled LDL to Platelets of Normolipemic Volunteers and Patients With Heterozygous Familial Hypercholesterolemia

  2005cites this paper
• Anticoagulants and Thrombolytic Agents in Cardiovascular Disease 'ombosis: Its Role Prevention in rdiovascuIar 3,nts Part

  2005cites this paper
• Blood Tests for the Diagnosis of Venous and Arterial Thrombosis

  2005cites this paper
• Pathological Changes in Acute Coronary Syndromes: The Role of Statin Therapy in the Modulation of Inflammation, Endothelial Function and Coagulation

  2004cites this paper
• Lipid rafts are critical membrane domains in blood platelet activation processes.

  2003cites this paper
• Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro.

  2002cites this paper
• Pravastatin down-regulates inflammatory mediators in human monocytes in vitro.

  2000cites this paper
• Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles.

  2000cites this paper
• Recipient of 1987 Scientific Presentation Award Preservation of Canine Platelets with Iloprost ( ZK 36374 ) during Extracorporeal Circulation

  1997cites this paper
• Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.

  1997cites this paper
• The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects.

  1997cites this paper
• Presented at the AmSECT 30 th International Conference March 13-16 , 1992 , Washington , D . C . The Effects of Heparin Bound Surface Modification ( Carmeda ® Bioactive Surface ) on Human Platelet Alterations During Simulated Extracorporeal Circulation

  1997cites this paper
• Differential eudismic ratios in the antagonism of human platelet function by phenoxy- and thiophenoxyacetic acids.

  1996cites this paper
• The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.

  1996cites this paper
• Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia.

  1995cites this paper
• No Association Between Serum Platelet-derived Growth Factor, Platelet Size, and Regression of Angiographically-defined Coronary Artery Disease.

  1994cites this paper
• Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients.

  1994cites this paper
• Binding of 111In-labeled LDL to platelets of normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.

  1993cites this paper
• Drugs Affecting Thrombosis and Atherosclerosis

  1993cites this paper
• Hypercholesterolemia and Platelets

  1993cites this paper
• Iloprost reduces procoagulant activity in the extracorporeal circuit.

  1993cites this paper
• Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.

  1993cites this paper
• Influences of lipid-modifying agents on hemostasis

  1993cites this paper
• Chiral α‐substituted α‐aryloxy acetic acids: Synthesis, absolute configuration, chemical resolution, and direct separation by hplc

  1992cites this paper
• The effects of heparin bound surface modification (Carmeda Bioactive Surface) on human platelet alterations during simulated extracorporeal circulation.

  1992cites this paper
• Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemia.

  1992cites this paper
• Is Heparin-Induced Platelet Activation an Unrecognized Cause of Thrombosis in Chronic Dialysis Patients?

  1992cites this paper
• Protection of Platelets During Long‐term Extracorporeal Membrane Oxygenation in Sheep With a Single Dose of a Disintegrin

  1992cites this paper
• Biochemical Pharmacology of Blood and Bloodforming Organs

  1992cites this paper
• Chemical Agents That Inhibit Platelet Aggregation

  1992cites this paper
• Cholesterol and lipoproteins: Beyond atherogenesis

  1992cites this paper
• Tolerability of fibric acids. Comparative data and biochemical bases.

  1992cites this paper
• The clinical importance of acquired abnormalities of platelet function.

  1991cites this paper
• Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels

  1991cites this paper
• Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability.

  1991cites this paper
• Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell Morphology

  1991cites this paper
• Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.

  1991cites this paper
• Thrombosis in relation to atherosclerosis

  1991cites this paper
• Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification by cholesterol-lowering agents.

  1990cites this paper
• Intraoperative management of patients with heparin-induced thrombocytopenia.

  1990cites this paper
• Heparin-induced thrombocytopenia in patients who undergo open heart surgery.

  1990cites this paper
• Hollow Fiber Membrane Oxygenator Reduces Platelet Loss During Simulated Extracorporeal Circulation

  1989cites this paper
• Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass.

  1989cites this paper
• Platelet Preservation During Simulated Cardiopulmonary Bypass Via Phosphodiesterase Inhibition

  1989cites this paper
• Heparin-induced platelet activation: the role of thromboxane A2 synthesis and the extent of platelet granule release in two patients.

  1989cites this paper
• Temporary inhibition of platelet function with iloprost (ZK36374) preserves canine platelets during extracorporeal membrane oxygenation.

  1988cites this paper
• Platelet Lipoprotein Interactions

  1988cites this paper
• Gemfibrozil decreases platelet reactivity in patients with hypercholesterolemia during physical stress

  1988cites this paper
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

  1988cites this paper
• Effects of verapamil and diltiazem on human platelet function.

  1987cites this paper
• Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.

  1987cites this paper
• Dietary and Pharmacological Control of Human and Experimental Hypercholesterolemia

  1987cites this paper
• 糖尿病患者の血中β-thromboglobulinおよび血漿脂質, アポ蛋白に対するPantethineの効果

  1987cites this paper
• Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations.

  1987cites this paper
• Dissociation of hypolipidemic and antiplatelet actions from adverse myotonic effects of clofibric acid related enantiomers.

  1987cites this paper
• Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).

  1987cites this paper
• Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.

  1987cites this paper
• Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).

  1987cites this paper
• Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management.

  1987cites this paper
• The heparin-induced thrombocytopenia syndrome: an update.

  1987cites this paper
• Platelet activation by plasma lipoproteins.

  1987cites this paper
• Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus.

  1987cites this paper
• Pharmacological treatment of lipid disorders in diabetes mellitus.

  1987cites this paper
• Preservation of Canine Platelets with Iloprost (ZK 36374) during Extracorporeal Circulation

  1987cites this paper
• Platelet activation in normo- and hyperlipoproteinemias

  1986cites this paper
• Platelets and antiplatelet therapy in ischemic heart disease.

  1986cites this paper
• In vivo platelet activity and lipoprotein patterns in coronary artery disease.

  1986cites this paper
• Comparative antiaggregatory activity in human platelets of a benzopyranone aci-reductone, clofibric acid, and a 2,3-dihydrobenzofuran analogue.

  1986cites this paper
• Platelet function in hypercholesterolemics before and after hypolipidemic drug therapy.

  1986cites this paper
• Platelets and antiplatelet therapy in ischemic heart disease.

  1986cites this paper
• The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.

  1986cites this paper
• Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.

  1985cites this paper
• The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.

  1985cites this paper
• [Diagnostic importance of the hemostatic system indices in peripheral atherosclerosis].

  1984cites this paper
• Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.

  1983cites this paper
• Contribution of thrombogenic factors to the pathogenesis of atherosclerosis.

  1983cites this paper
• 4 – Pharmacology of Antiplatelet Agents and Their Role in Coronary Disease

  1983cites this paper
• Platelet-Vessel Wall Interactions in Human and Experimental Hypercholesterolemia

  1983cites this paper
• DRUG CONTROL OF HYPERCHOLESTEREMIA AND PLATELET FUNCTION

  1983cites this paper
• Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.

  1982cites this paper
• Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.

  1982cites this paper
• THE ROLE OF PLATELETS IN THE GENESIS OF ISCHEMIA *

  1982cites this paper
• Inhibition of human platelet function by verapamil.

  1982cites this paper
• Specific binding sites on human blood platelets for plasma lipoproteins.

  1982cites this paper
• Hyperlipoproteinemia as a significant risk factor for pulmonary embolism in patients undergoing coronary artery bypass grafting.

  1982cites this paper
• Effects of clofibrate and 6-substituted chroman analogs on human platelet function: mechanism of inhibitory action.

  1981cites this paper
• Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.

  1981cites this paper
• Blood tests for the diagnosis of venous and arterial thrombosis.

  1981cites this paper